Type: Liver cancer

Researchers will investigate a new treatment approach that combines a new drug delivery method capable of specifically targeting the liver.

Professor McCaughan’s team will test two potential new treatments which target HCC liver cancer cells.

If successful, this study should significantly improve the patient care of those suffering with advanced liver cancer by making drug treatment more effective.

Dr Lionel Hebbard and his team conducted a long-range study that aimed to quantify the exact impact of metabolic drivers, particularly obesity, on liver cancer prognosis and progression in patients.

This project will evaluate the impact of improved chronic hepatitis C (HCV) treatment on liver cancer incidence and survival.